Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Research highlights the benefits of physical activity for older adults

Physically active older adults benefit from reduced risks of early death, breast and prostate cancer, fractures, recurrent falls, functional limitations, cognitive decline, dementia, Alzheimer's disease, and depression.

5 Feb 2020

Flickering light triggers the brain to release signaling chemicals that may help fight Alzheimer's

For over a century, Alzheimer's disease has confounded all attempts to treat it. But in recent years, perplexing experiments using flickering light have shown promise.

4 Feb 2020

Women’s Heart Fund announces launch of ‘Community Conversations with the CDI’

The Women's Heart Fund, a philanthropic arm of Hackensack Meridian Health Meridian Health Foundation, has announced that for its newest venture, the organization will sponsor 'Community Conversations with the CDI,' a women-focused, three-year lecture series featuring researchers from Hackensack Meridian Health's Center for Discovery and Innovation.

3 Feb 2020

Blood test can be used to gauge a person's risk for cerebral small vessel disease

A UCLA-led study has found that levels of six proteins in the blood can be used to gauge a person's risk for cerebral small vessel disease, or CSVD, a brain disease that affects an estimated 11 million older adults in the U.S. CSVD can lead to dementia and stroke, but currently it can only be diagnosed with an MRI scan of the brain.

3 Feb 2020

New compound prevents amyloid formation to fight Alzheimer’s disease

It is known that Alzheimer’s disease is caused by the formation of amyloid plaques and tau tangles in the brain. A novel compound shows promise in preventing amyloid formation, fighting Alzheimer’s disease development.

3 Feb 2020

Regular aerobic exercise could enhance cognitive functions in adults at risk for Alzheimer’s

Individuals at risk for Alzheimer's disease (AD) because of family history or genetic predisposition who engaged in six months of aerobic exercise training improved their brain glucose metabolism and higher-order thinking abilities (e.g., planning and mental flexibility) called executive function; these improvements occurred in conjunction with increased cardiorespiratory fitness.

3 Feb 2020

New noninvasive way to monitor the health of brain cells using an infrared laser

With no way to reliably tell whether an athlete has a concussion, many may be playing with an undiagnosed injury. Likewise, 2 million people die every year because we don't have an early warning when brain cells are dying--and another 4 million experience cognitive disabilities.

3 Feb 2020

Plant flavonols significantly reduce Alzheimer’s risk

A new study published in the journal Neurology in January 2020 concludes that increasing the intake of plant flavonols steeply reduces the risk of Alzheimer’s dementia (AD) by up to a half. In other words, AD could be prevented in many people simply by regularly eating more of foods containing these compounds such as tea, oranges and broccoli.

2 Feb 2020

MSU researcher makes strides in discovering new cellular mechanism

A Montana State University biotechnology researcher was part of an international team that recently discovered an internal mechanism which may protect human cells from oxidative damage.

30 Jan 2020

Scientists discover small molecule that may slow or stop Parkinson's disease progression

A collaboration between scientists at Rutgers University and Scripps Research led to the discovery of a small molecule that may slow down or stop the progression of Parkinson's disease.

30 Jan 2020

A high flavonol intake could lower the risk for Alzheimer’s dementia

Older people with a high intake of the antioxidant flavanol may be less likely to develop Alzheimer’s dementia, compared with those who have a low intake.

30 Jan 2020

Study opens up strategies for early diagnosis, treatment of diseases linked to chronic inflammation

Claudio Franceschi, a world-renowned scientist, professor at the University of Bologna (Italy) and head of the Research Laboratory for Systems Medicine of Healthy Aging at Lobachevsky University, together with other members of an international research team, has described the mechanisms underlying chronic inflammation and identified several risk factors leading to disease.

29 Jan 2020

High intake of dietary flavonols tied to lower risk of Alzheimer's dementia

People who eat or drink more foods with the antioxidant flavonol, which is found in nearly all fruits and vegetables as well as tea, may be less likely to develop Alzheimer's dementia years later, according to a study published in the January 29, 2020, online issue of Neurology, the medical journal of the American Academy of Neurology.

29 Jan 2020

Buck study uncovers how astrocyte senescence promotes neurodegeneration

Although a link has been established between chronic inflammation and neurodegenerative diseases, there have been many open questions regarding how cellular senescence, a process whereby cells that stop dividing under stress spew out a mix of inflammatory proteins, affects these pathologies.

29 Jan 2020

Portable device to monitor blink reflex receives FDA clearance

EyeStat (blinktbi, Charleston, SC), a portable, lightweight device for measuring the natural blink reflex, received clearance by the U.S. Food and Drug Administration in December 2019.

29 Jan 2020

New way to treat stroke using an already FDA-approved drug shows promise

Stroke is the third leading cause of death and disability in the United States. More than 87 percent are ischemic strokes, caused by obstruction of one or more cerebral arteries. With limited progress in developing treatments, there is a critical need for neuroprotective agents to effectively treat stroke.

29 Jan 2020

New AI tool predicts disease progression and evolution in neurodegenerative disorders

Researchers have found that testing blood using an artificial intelligence algorithm successfully predicted disease progression in neurodegenerative disorders.

28 Jan 2020

AI analysis of blood samples can predict progression of neurodegenerative disease

Evaluating the effectiveness of therapies for neurodegenerative diseases is often difficult because each patient's progression is different.

28 Jan 2020

Mysterious large holes in cells linked with sense of taste, Alzheimer's disease, asthma

Many cells are covered with mysterious large holes, pores that have been associated with the sense of taste as well as Alzheimer's disease, depression, and even asthma. Knowing the structure of these varied holes will help researchers better understand this range of associations and provide a blueprint for developing new therapies.

27 Jan 2020

ISS researchers estimated 680,000 cases of mild cognitive impairment in 2018

In a study published in the Journal of Alzheimer's Disease, ISS researchers estimated about 680,000 cases of mild cognitive impairment (MCI), in a total of 12,730,960 migrants, aged between 60 and 89 years, living in the European Union in 2018.

27 Jan 2020

Alzheimer's Disease News and Research

Further Reading

Research highlights the benefits of physical activity for older adults

Flickering light triggers the brain to release signaling chemicals that may help fight Alzheimer's

Women’s Heart Fund announces launch of ‘Community Conversations with the CDI’

Blood test can be used to gauge a person's risk for cerebral small vessel disease

New compound prevents amyloid formation to fight Alzheimer’s disease

Regular aerobic exercise could enhance cognitive functions in adults at risk for Alzheimer’s

New noninvasive way to monitor the health of brain cells using an infrared laser

Plant flavonols significantly reduce Alzheimer’s risk

MSU researcher makes strides in discovering new cellular mechanism

Scientists discover small molecule that may slow or stop Parkinson's disease progression

A high flavonol intake could lower the risk for Alzheimer’s dementia

Study opens up strategies for early diagnosis, treatment of diseases linked to chronic inflammation

High intake of dietary flavonols tied to lower risk of Alzheimer's dementia

Buck study uncovers how astrocyte senescence promotes neurodegeneration

Portable device to monitor blink reflex receives FDA clearance

New way to treat stroke using an already FDA-approved drug shows promise

New AI tool predicts disease progression and evolution in neurodegenerative disorders

AI analysis of blood samples can predict progression of neurodegenerative disease

Mysterious large holes in cells linked with sense of taste, Alzheimer's disease, asthma

ISS researchers estimated 680,000 cases of mild cognitive impairment in 2018

Industry Focus eBook - Neurology/Neuroscience - 2nd edition eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News